Breaking News

Bayer Drops Out in the Race for Schiff

November 20, 2012

According to published reports, Bayer AG has ceased its pursuit of Schiff Nutrition International Inc., ending speculation that the deal was poised to become the industry’s most expensive acquisition.

Late last month German drugmaker Bayer announced its intent to buy Schiff for $34 a share, or about $1.1 billion including net debt, according to Bloomberg. The situation grew interesting when Reckitt Benckiser Group Plc made a surprise offer of $42 a share, or about $1.4 billion.

In a filing with the U.S. Securities and Exchange Commission Bayer said that a competitive bidding process “would result in a price outside Bayer’s set financial criteria.”

blog comments powered by Disqus
  • Nature-Based Adipose Management Cosmetics

    Nature-Based Adipose Management Cosmetics

    John Stanek, Melinda Wochner and Shyam Gupta, CoValence Laboratories and Bioderm Research ||September 1, 2015
    The number of scientifically driven topical ingredients for body sculpting and adipose management is quickly growing.

  • Are You Aging Well?

    Are You Aging Well?

    Mark Menolascino, MD, Meno Clinic Center for Advanced Medicine||September 1, 2015
    How the future of anti-aging medicine and targeted nutritional supplementation will help achieve the optimal aging process.

  • Foods for Thought… And Healthier Skin!

    Foods for Thought… And Healthier Skin!

    Tom Branna, Editorial Director||September 1, 2015
    Here’s a look at some of the newest edible ingredients that are finding their way into today’s beauty routines.